Increased cell apoptosis in human lung adenocarcinoma and in vivo tumor growth inhibition by RBM10, a tumor suppressor gene

Ji,Yunxi; Xie,Sheng; Jiang,Li; Liu,Lijian; Li,Liumei; Luo,Lichuan; Chen,Yan; Zhang,Jianxuan; Yu,Lei; Zhang,Yaozhong; Tang,Nong; Liu,Bugu

doi:10.3892/ol.2017.6765

Increased cell apoptosis in human lung adenocarcinoma and in vivo tumor growth inhibition by RBM10, a tumor suppressor gene

Authors:
- Yunxi Ji
- Sheng Xie
- Li Jiang
- Lijian Liu
- Liumei Li
- Lichuan Luo
- Yan Chen
- Jianxuan Zhang
- Lei Yu
- Yaozhong Zhang
- Nong Tang
- Bugu Liu
View Affiliations

Affiliations: Department of Gastroenterology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530000, P.R. China, Department of Oncology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi 530000, P.R. China, School of Graduate Study, Guangxi University of Chinese Medicine, Nanning, Guangxi 530000, P.R. China, School of Graduate Study, Hunan University of Chinese Medicine, Changsha, Hunan 410000, P.R. China
Published online on: August 17, 2017 https://doi.org/10.3892/ol.2017.6765
Pages: 4663-4669
Copyright: © Ji et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor suppressor genes are frequently deleted or mutated in lung cancer. The RNA‑binding motif protein 10 (RBM10) gene has the ability to suppress tumor activity, but the role of RBM10 during the development of lung cancer has yet to be elucidated. The current study investigated the expression levels of RBM10 in non‑tumor and tumor tissues obtained from patients with adenocarcinoma using reverse transcription‑polymerase chain reaction and western blot analysis, and identified a reduction in RBM10 expression in lung tumor tissue. To investigate the in vitro and in vivo function of RBM10, A549 human non‑small cell lung cancer cells were transfected with the pcDNA‑RBM10 vector. Flow cytometry was used to analyze the levels of apoptosis in the transfected cells. Western blot analysis was used to evaluate the expression of B‑cell lymphoma 2 (Bcl‑2), cleaved caspase‑3, caspase‑9 and poly (ADP‑ribose) polymerase (PARP) proteins in A549 cells and tissues from the A549 xenograft Bagg Albino coat (BALB/c) nude mice model. RBM10 mRNA levels were significantly decreased in adenocarcinoma cells, but not in the non‑tumor tissues. The A549 cells and tumor tissues exhibited significant growth inhibition following transfection with the pcDNA‑RBM10 vector, which was determined using a cell proliferation assay. Flow cytometry analysis of cells stained with Annexin V/propidium iodide indicated that the overexpression of RBM10 induced apoptosis in A549 cells. The present study demonstrated that the expression levels of Bcl‑2 protein were decreased and the expression levels of cleaved caspase‑3, caspase‑9 and PARP proteins were significantly increased in the A549 cells and cells from ex vivo tumor tissues that were injected with RBM10 vector‑containing Salmonella enterica subspecies enterica serovar typhimurium. Notably, the current study identified that the accumulated and stable overexpression of RBM10 in the xenograft BALB/c nude mice model significantly inhibited the tumor growth rate. These results may provide novel insights into the use of RBM10 for lung cancer diagnosis and therapy.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Reck M, Heigener DF, Mok T, Soria JC and Rabe KF: Management of non-small-cell lung cancer: Recent developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
3	Decroisette C, Galerneau LM, Hominal S and Chouaid C: Epidemiology, management and cost of bone metastases from lung cancer. Rev Mal Respir. 30:309–315. 2013.(In French). View Article : Google Scholar : PubMed/NCBI
4	Romeo MS, Sokolova IA, Morrison LE, Zeng C, Barón AE, Hirsch FR, Miller YE, Franklin WA and Varella-Garcia M: Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn. 5:103–112. 2003. View Article : Google Scholar : PubMed/NCBI
5	Massion PP and Carbone DP: The molecular basis of lung cancer: Molecular abnormalities and therapeutic implications. Respir Res. 4:122003. View Article : Google Scholar : PubMed/NCBI
6	Masuda A and Takahashi T: Chromosome instability in human lung cancers: Possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene. 21:6884–6897. 2002. View Article : Google Scholar : PubMed/NCBI
7	Glisovic T, Bachorik JL, Yong J and Dreyfuss G: RNA-binding proteins and post-transcriptional gene regulation. FEBS Lett. 582:1977–1986. 2008. View Article : Google Scholar : PubMed/NCBI
8	Sutherland LC, Rintala-Maki ND, White RD and Morin CD: RNA binding motif (RBM) proteins: A novel family of apoptosis modulators? J Cell Biochem. 94:5–24. 2005. View Article : Google Scholar : PubMed/NCBI
9	Zhang JY, Chan EK, Peng XX and Tan EM: A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med. 189:1101–1110. 1999. View Article : Google Scholar : PubMed/NCBI
10	Xin H, Deng K and Fu M: Post-transcriptional gene regulation by RNA-binding proteins in vascular endothelial dysfunction. Sci China Life Sci. 57:836–844. 2014. View Article : Google Scholar : PubMed/NCBI
11	Gerstberger S, Hafner M, Ascano M and Tuschl T: Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease. Adv Exp Med Biol. 825:1–55. 2014. View Article : Google Scholar : PubMed/NCBI
12	Kim MY, Hur J and Jeong S: Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep. 42:125–130. 2009. View Article : Google Scholar : PubMed/NCBI
13	Lukong KE, Chang KW, Khandjian EW and Richard S: RNA-binding proteins in human genetic disease. Trends Genet. 24:416–425. 2008. View Article : Google Scholar : PubMed/NCBI
14	Musunuru K: Cell-specific RNA-binding proteins in human disease. Trends Cardiovasc Med. 13:188–195. 2003. View Article : Google Scholar : PubMed/NCBI
15	Kumar R, Vadlamudi RK and Adam L: Apoptosis in mammary gland and cancer. Endocr Relat Cancer. 7:257–269. 2000. View Article : Google Scholar : PubMed/NCBI
16	Motyl T, Gajkowska B, Zarzynska J, Gajewska M and Lamparska-Przybysz M: Apoptosis and autophagy in mammary gland remodeling and breast cancer chemotherapy. J Physiol Pharmacol. 57 Suppl 7:S17–S32. 2006.
17	Kechavarzi B and Janga SC: Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 15:R142014. View Article : Google Scholar : PubMed/NCBI
18	Shao C, Zhao L, Wang K, Xu W, Zhang J and Yang B: The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis. World J Surg Oncol. 10:1602012. View Article : Google Scholar : PubMed/NCBI
19	Martinez-Arribas F, Agudo D, Pollán M, Gómez-Esquer F, Díaz-Gil G, Lucas R and Schneider J: Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem. 97:1275–1282. 2006. View Article : Google Scholar : PubMed/NCBI
20	Tzifi F, Economopoulou C, Gourgiotis D, Ardavanis A, Papageorgiou S and Scorilas A: The role of BCL2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv Hematol. 2012:5243082012.PubMed/NCBI
21	Alberg AJ and Nonemaker J: Who is at high risk for lung cancer? Population-level and individual-level perspectives. Semin Respir Crit Care Med. 29:223–232. 2008. View Article : Google Scholar : PubMed/NCBI
22	Buyukcelik A, Yalcin B and Utkan G: Multidisciplinary management of lung cancer. N Engl J Med. 350:2008–2010. 2004. View Article : Google Scholar : PubMed/NCBI
23	Spira A and Ettinger DS: Multidisciplinary management of lung cancer. N Engl J Med. 350:379–392. 2004. View Article : Google Scholar : PubMed/NCBI
24	Martin-Garabato E, Martinez-Arribas F, Pollán M, Lucas AR, Sánchez J and Schneider J: The small variant of the apoptosis-associated X-chromosome RBM10 gene is co-expressed with caspase-3 in breast cancer. Cancer Genomics Proteomics. 5:169–173. 2008.PubMed/NCBI
25	Wang K, Bacon ML, Tessier JJ, Rintala-Maki ND, Tang V and Sutherland LC: RBM10 modulates apoptosis and influences TNF-α gene expression. J Cell Death. 5:1–19. 2012.PubMed/NCBI
26	Delbridge AR and Strasser A: The BCL-2 protein family, BH3-mimetics and cancer therapy. Cell Death Differ. 22:1071–1080. 2015. View Article : Google Scholar : PubMed/NCBI
27	Ziegler A, Luedke GH, Fabbro D, Altmann KH, Stahel RA and Zangemeister-Wittke U: Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J Natl Cancer Inst. 89:1027–1036. 1997. View Article : Google Scholar : PubMed/NCBI
28	Glantz LA, Gilmore JH, Lieberman JA and Jarskog LF: Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res. 81:47–63. 2006. View Article : Google Scholar : PubMed/NCBI
29	Pang H, Flinn R, Patsialou A, Wyckoff J, Roussos ET, Wu H, Pozzuto M, Goswami S, Condeelis JS, Bresnick AR, et al: Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase. Cancer Res. 69:8868–8876. 2009. View Article : Google Scholar : PubMed/NCBI
30	Camacho EM, Mesa-Pereira B, Medina C, Flores A and Santero E: Engineering Salmonella as intracellular factory for effective killing of tumour cells. Sci Rep. 6:305912016. View Article : Google Scholar : PubMed/NCBI
31	Li X, Fu GF, Fan YR, Liu WH, Liu XJ, Wang JJ and Xu GX: Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther. 10:105–111. 2003. View Article : Google Scholar : PubMed/NCBI
32	Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J, et al: Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol. 17:37–41. 1999. View Article : Google Scholar : PubMed/NCBI
33	Theys J, Landuyt W, Nuyts S, Van Mellaert L, van Oosterom A, Lambin P and Anné J: Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum. Cancer Gene Ther. 8:294–297. 2001. View Article : Google Scholar : PubMed/NCBI
34	Lerman MI and Minna JD: The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes. The international lung cancer chromosome 3p21.3 tumor suppressor gene consortium. Cancer Res. 60:6116–6133. 2000.PubMed/NCBI
35	Swanton E, Savory P, Cosulich S, Clarke P and Woodman P: Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene. 18:1781–1787. 1999. View Article : Google Scholar : PubMed/NCBI
36	Wu GS and Ding Z: Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line. Oncogene. 21:1–8. 2002. View Article : Google Scholar : PubMed/NCBI
37	Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S and Smulson M: Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem. 274:22932–22940. 1999. View Article : Google Scholar : PubMed/NCBI